Novavax
NVAX
#5751
Rank
HK$8.74 B
Marketcap
HK$53.79
Share price
0.73%
Change (1 day)
-16.71%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): HK$2.92 Billion

According to Novavax's latest financial reports the company's current earnings are HK$1.02 Billion. In 2024 the company made an earning of -HK$1.22 Billion, an increase over its 2023 earnings that were of -HK$4.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$2.92 B-340.09%
2024 -HK$1.22 Billion-70.39%
2023 -HK$4.12 Billion-16.59%
2022 -HK$4.94 Billion-62.58%
2021 -HK$13.19 Billion320.54%
2020 -HK$3.14 Billion234.22%
2019 -HK$0.94 Billion-30.17%
2018 -HK$1.35 Billion1.69%
2017 -HK$1.33 Billion-36.44%
2016 -HK$2.08 Billion70.4%
2015 -HK$1.22 Billion89.27%
2014 -HK$0.65 Billion59.83%
2013 -HK$0.41 Billion81.9%
2012 -HK$0.23 Billion50.33%
2011 -HK$0.15 Billion
2009 -HK$0.3 Billion8.8%
2008 -HK$0.27 Billion18.01%
2007 -HK$0.23 Billion18.33%
2006 -HK$0.2 Billion168.31%
2005 -HK$71.4 Million-62.51%
2004 -HK$0.2 Billion52.4%
2003 -HK$0.13 Billion-28.21%
2002 -HK$0.18 Billion
2000 -HK$99.2 Million177%
1999 -HK$35.81 Million-11.54%
1998 -HK$40.48 Million10.64%
1997 -HK$36.59 Million-9.62%
1996 -HK$40.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
HK$0.16 B-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-HK$1.97 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.28 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$51.52 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$101.90 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$92.26 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.81 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-HK$73.7 Million-102.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$72.57 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-HK$2 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA